Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-22
DOI
10.1038/s41598-021-85930-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The impact of ABCB1 gene polymorphism and its expression on non-small-cell lung cancer development, progression and therapy – preliminary report
- (2020) Izabela Zawadzka et al. Scientific Reports
- MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells
- (2020) Rui Jia et al. Cancer Management and Research
- RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types
- (2019) Gianni Monaco et al. Cell Reports
- Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells
- (2019) Ilda Theka et al. Scientific Reports
- The Roles of MicroRNA in Lung Cancer
- (2019) Kuan-Li Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
- (2019) A K M Nawshad Hossian et al. Jove-Journal of Visualized Experiments
- Sphingosine kinase‑1 predicts overall survival outcomes in non‑small cell lung cancer patients treated with carboplatin and navelbine
- (2019) Mariam Gachechiladze et al. Oncology Letters
- The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line
- (2019) Chengji Jin et al. Oncology Letters
- Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
- (2019) Michael Schulz et al. Frontiers in Immunology
- Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
- (2019) Jeonghun Han et al. Journal of Oncology
- S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway
- (2019) Yan Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β‑catenin signaling pathway
- (2019) Qing Wang et al. Oncology Letters
- Knockdown of SP1/Syncytin1 axis inhibits the proliferation and metastasis through the AKT and ERK1/2 signaling pathways in non‐small cell lung cancer
- (2019) Xiaohui Li et al. Cancer Medicine
- SPINK1 is a prognosis predicting factor of non‑small cell lung cancer and regulates redox homeostasis
- (2019) Maoqing Guo et al. Oncology Letters
- Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
- (2019) De Angelis et al. Cancers
- TREM-1 Neutrophil Activation Pathway Is Suppressed in Eosinophilic Nasal Polyps
- (2018) Dawei Wu et al. American Journal of Rhinology & Allergy
- Roles of protein kinase R in cancer: Potential as a therapeutic target
- (2018) Takao Watanabe et al. CANCER SCIENCE
- Transcriptome analysis of the typical freshwater rhodophytes Sheathia arcuata grown under different light intensities
- (2018) Fangru Nan et al. PLoS One
- The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications (Review)
- (2018) Lei Wu et al. Oncology Letters
- MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1
- (2018) Hui Liu et al. Oncotarget
- MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1
- (2018) Chongyu Su et al. Cancer Medicine
- HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer
- (2018) Chih-Yang Huang et al. Cell Death & Disease
- Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro
- (2018) A. K. M. Nawshad Hossian et al. Scientific Reports
- Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer
- (2018) Andreas Kuemmel et al. Scientific Reports
- Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
- (2018) IA Silva Junior et al. Clinics
- The progression of HMGB1-induced autophagy in cancer biology
- (2018) Tianwei Xu et al. OncoTargets and Therapy
- miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma
- (2018) Wei Xu et al. MEDICAL SCIENCE MONITOR
- Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment
- (2018) Ilze Mentoor et al. Frontiers in Endocrinology
- Chemoresistance and the Self-Maintaining Tumor Microenvironment
- (2018) Gulcen Yeldag et al. Cancers
- The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis
- (2017) N. Afifiyan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance
- (2017) Veronica Lifshitz et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
- (2017) Navin Sarin et al. PLoS One
- TREM-1 promotes intestinal tumorigenesis
- (2017) Leslie Saurer et al. Scientific Reports
- Progress and prospects of early detection in lung cancer
- (2017) Sean Blandin Knight et al. Open Biology
- Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
- (2017) Ildefonso Alves da Silva Junior et al. Journal of Immunology Research
- miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
- (2017) S-L Tung et al. Oncogenesis
- Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells
- (2017) Yani Fang et al. PLoS One
- Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line
- (2016) Angui Li et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC
- (2016) Qijian Cheng et al. ONCOLOGY REPORTS
- Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer
- (2016) George Mattheolabakis et al. PHARMACEUTICAL RESEARCH
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
- (2016) Romaine I. Fernando et al. Oncotarget
- Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway
- (2016) Jiali Yang et al. Stem Cells International
- Wnt pathway activation and ABCB1 expression account for attenuation of Proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells
- (2015) Kowit Yu Chong et al. CANCER BIOLOGY & THERAPY
- MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer
- (2015) Ying Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?
- (2015) Srilakshmi Srinivasan et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review
- (2015) Xuanbin Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The HMGB1 signaling pathway activates the inflammatory response in Schwann cells
- (2015) Yong-jun Wang et al. Neural Regeneration Research
- Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis
- (2015) Ruiguang Zhang et al. TUMOR BIOLOGY
- Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
- (2014) R. P. Sahu et al. CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Innate Immune Responses to TREM-1 Activation: Overlap, Divergence, and Positive and Negative Cross-Talk with Bacterial Lipopolysaccharide
- (2014) K. Dower et al. JOURNAL OF IMMUNOLOGY
- Sphingosine 1-Phosphate Receptor-1 Enhances Mitochondrial Function and Reduces Cisplatin-Induced Tubule Injury
- (2014) A. Bajwa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells
- (2014) Liancheng Zhu et al. MEDICAL ONCOLOGY
- ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines
- (2014) YING TANG et al. ONCOLOGY REPORTS
- TREM-1 Is Induced in Tumor Associated Macrophages by Cyclo-Oxygenase Pathway in Human Non-Small Cell Lung Cancer
- (2014) Zhihong Yuan et al. PLoS One
- Aberrant microRNA Expression Likely Controls RAS Oncogene Activation During Malignant Transformation of Human Prostate Epithelial and Stem Cells by Arsenic
- (2014) Ntube N. O. Ngalame et al. TOXICOLOGICAL SCIENCES
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells
- (2013) Yuan Gao et al. CANCER LETTERS
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-8 in Breast Cancer Progression
- (2013) Nataša Todorović-Raković et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Wnt Signaling Pathway in Non-Small Cell Lung Cancer
- (2013) D. J. Stewart JNCI-Journal of the National Cancer Institute
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Differences in gene expression profiles and carcinogenesis pathways involved in cisplatin resistance of four types of cancer
- (2013) YONG YANG et al. ONCOLOGY REPORTS
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- Transcriptome sequencing of neonatal thymic epithelial cells
- (2013) Charles St-Pierre et al. Scientific Reports
- Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
- (2012) Stephany Corrêa et al. BMC CANCER
- Cholesterol metabolism and cancer: the good, the bad and the ugly
- (2012) Sandrine Silvente-Poirot et al. CURRENT OPINION IN PHARMACOLOGY
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff
- (2012) Pablo Cingolani et al. FLY
- Tec Family Kinases in Inflammation and Disease
- (2012) Nicole J. Horwood et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors
- (2012) R. J. W. Arts et al. JOURNAL OF LEUKOCYTE BIOLOGY
- miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
- (2012) S Catuogno et al. ONCOGENE
- Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
- (2011) James W. Antoon et al. CANCER BIOLOGY & THERAPY
- M2-Polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma
- (2011) Bicheng Zhang et al. Clinics
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- The Role of PKR/eIF2α Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer
- (2011) Yong He et al. PLoS One
- Sphingosine-1-phosphate signaling and its role in disease
- (2011) Michael Maceyka et al. TRENDS IN CELL BIOLOGY
- Small insertions and deletions (INDELs) in human genomes
- (2010) J. M. Mullaney et al. HUMAN MOLECULAR GENETICS
- Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
- (2010) Yan Ning et al. INTERNATIONAL JOURNAL OF CANCER
- Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
- (2009) N. F. Krynetskaia et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line
- (2008) Jin Kyung Rho et al. LUNG CANCER
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer
- (2007) Chao-Chi Ho et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started